Skip to main content
. 2022 Aug 18;10:e13922. doi: 10.7717/peerj.13922

Figure 5. External validation of the five-cholesterogenic-gene signature in GSE133769.

Figure 5

130 young breast cancer patients were divided into high risk and low risk group by median risk score. The low risk group showed better survival outcome than high risk group (P = 0.033).